Blog


Is Mandatory Participation in Medicare Demonstrations Necessary?

May 25, 2022

Recently, Health Affairs Forefront, published a post by Dan L. Crippen, former director of the Congressional Budget Office and currently a Healthcare Leaddership Council consultant, that should be a catalyst … Continued


Americans Deserve the Full Truth About Medicare-For-All and its Ramifications for their Healthcare

May 4, 2022

So much of the nation’s discussion about the Medicare-for-all concept takes place through a political prism.  It’s important, though, to fully understand what such a drastic change to our healthcare … Continued


Lawmakers Have a Drug Pricing Solution Right in Front of Them

October 4, 2021

As Congress continues to deliberate on drug pricing proposals that many would call extreme, even radical – empowering the federal government to set prices instead of having prices negotiated in … Continued


The Problematic Push to Slow Medicare Advantage’s Positive Health Impact

September 23, 2021

In the complex deliberations on Capitol Hill to assemble a social spending package that can pass both houses, one of the prominent proposals being discussed is the expansion of Medicare … Continued


We Need a Patient-Centered Approach to Pharmaceutical Affordability

October 7, 2020

There is universal agreement in our country that lifesaving and life-strengthening treatments and therapies should be widely accessible and affordable. The question is how to achieve this objective in a … Continued


Addressing the Unintended Consequences of the Stark Law and Anti-Kickback Statute

October 12, 2016

In the new era of healthcare in which value-based care is steadily pushing aside the fee-for-service model, outdated rules and regulations continue to hinder the progress of healthcare reform. The … Continued


Let the Public Option Rest in Peace

August 24, 2016

Most will remember that one of the most spirited debates during congressional consideration of the Affordable Care Act, back in the early days of the Obama administration, concerned the proposed … Continued


Campaigns, Honesty and the Future of Medicare

August 17, 2016

It’s like a bad rerun, but one with real consequences.  Every two years, some political candidates and the interest groups that support them decide the best way to boost their … Continued


A Decade of Proving Critics Wrong

July 27, 2016

As it was enacted into law in 2003, the Medicare prescription drug benefit, which would come to be known as Medicare Part D, had no shortage of critics.  A New … Continued


The Trustees Report and the Need for Action

June 22, 2016

On a day in which the House Republicans are announcing their alternative health reform plan, House Democrats are staging a sit-in over gun laws, and the presumptive presidential nominees are … Continued